RRM2 and cancer: Kaplan–Meier survival curves of prognostic value analysis revealed that high RRM2 expression predicted poorer OS in ACC, KIRC, KIRP, LGG, LIHC, LUAD, and PAAD, indicating that RRM2 is a risk factor in these cancers.